CVS HEALTH CORPORATION Debt Securities, Available-for-sale, Realized Gain
CVS HEALTH CORPORATION (CVS) reported Debt Securities, Available-for-sale, Realized Gain of $18.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGain · last filed 2026-08-05
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized gain for the quarter ending 2026-06-30 was $18.00M, a 80.00% increase year-over-year.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized gain for the quarter ending 2026-03-31 was $27.00M, a 125.00% increase year-over-year.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized gain for the quarter ending 2025-12-31 was $31.00M, a 342.86% increase year-over-year.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized gain for the quarter ending 2025-09-30 was $15.00M, a 6.25% decline year-over-year.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized gain for fiscal 2025 was $68.00M, a 83.78% increase from fiscal 2024.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized gain for fiscal 2024 was $37.00M, a 311.11% increase from fiscal 2023.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized gain for fiscal 2023 was $9.00M, a 62.50% decline from fiscal 2022.
- CVS HEALTH CORPORATION debt securities, available-for-sale, realized gain for fiscal 2022 was $24.00M, a 66.67% decline from fiscal 2021.
| Period end | Debt Securities, Available-for-sale, Realized Gain 3 month | Debt Securities, Available-for-sale, Realized Gain 6 month | Debt Securities, Available-for-sale, Realized Gain 9 month | Debt Securities, Available-for-sale, Realized Gain 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.00M 10-Q · filed 2026-08-05 | $45.00M 10-Q · filed 2026-08-05 | $76.00M derived: sum of 3 quarters · filed 2026-08-05 | $91.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $27.00M 10-Q · filed 2026-05-06 | $58.00M derived: sum of 2 quarters · filed 2026-05-06 | $73.00M derived: sum of 3 quarters · filed 2026-05-06 | $83.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $46.00M derived: sum of 2 quarters · filed 2026-02-10 | $56.00M derived: sum of 3 quarters · filed 2026-08-05 | $68.00M 10-K · filed 2026-02-10 |
| 2025-09-30 | $15.00M 10-Q · filed 2025-10-29 | $25.00M derived: sum of 2 quarters · filed 2026-08-05 | $37.00M 10-Q · filed 2025-10-29 | $44.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $10.00M 10-Q · filed 2026-08-05 | $22.00M 10-Q · filed 2026-08-05 | $29.00M derived: sum of 3 quarters · filed 2026-08-05 | $45.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $12.00M 10-Q · filed 2026-05-06 | $19.00M derived: sum of 2 quarters · filed 2026-05-06 | $35.00M derived: sum of 3 quarters · filed 2026-05-06 | $41.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $23.00M derived: sum of 2 quarters · filed 2026-02-10 | $29.00M derived: sum of 3 quarters · filed 2026-02-10 | $37.00M 10-K · filed 2026-02-10 |
| 2024-09-30 | $16.00M 10-Q · filed 2025-10-29 | $22.00M derived: sum of 2 quarters · filed 2025-10-29 | $30.00M 10-Q · filed 2025-10-29 | $32.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $6.00M 10-Q · filed 2025-07-31 | $14.00M 10-Q · filed 2025-07-31 | $16.00M derived: sum of 3 quarters · filed 2026-02-10 | $18.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $8.00M 10-Q · filed 2025-05-01 | $10.00M derived: sum of 2 quarters · filed 2026-02-10 | $12.00M derived: sum of 3 quarters · filed 2026-02-10 | $14.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $4.00M derived: sum of 2 quarters · filed 2026-02-10 | $6.00M derived: sum of 3 quarters · filed 2026-02-10 | $9.00M 10-K · filed 2026-02-10 |
| 2023-09-30 | $2.00M 10-Q · filed 2024-11-06 | $4.00M derived: sum of 2 quarters · filed 2024-11-06 | $7.00M 10-Q · filed 2024-11-06 | $11.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $2.00M 10-Q · filed 2024-08-07 | $5.00M 10-Q · filed 2024-08-07 | $9.00M derived: sum of 3 quarters · filed 2025-02-12 | $12.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $3.00M 10-Q · filed 2024-05-01 | $7.00M derived: sum of 2 quarters · filed 2025-02-12 | $10.00M derived: sum of 3 quarters · filed 2025-02-12 | $13.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $7.00M derived: sum of 2 quarters · filed 2025-02-12 | $10.00M derived: sum of 3 quarters · filed 2025-02-12 | $24.00M 10-K · filed 2025-02-12 |
| 2022-09-30 | $3.00M 10-Q · filed 2023-11-01 | $6.00M derived: sum of 2 quarters · filed 2023-11-01 | $20.00M 10-Q · filed 2023-11-01 | $31.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $3.00M 10-Q · filed 2023-08-02 | $17.00M 10-Q · filed 2023-08-02 | $28.00M derived: sum of 3 quarters · filed 2024-02-07 | $47.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $14.00M 10-Q · filed 2023-05-03 | $25.00M derived: sum of 2 quarters · filed 2024-02-07 | $44.00M derived: sum of 3 quarters · filed 2024-02-07 | $64.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $30.00M derived: sum of 2 quarters · filed 2024-02-07 | $50.00M derived: sum of 3 quarters · filed 2024-02-07 | $72.00M 10-K · filed 2024-02-07 |
| 2021-09-30 | $19.00M 10-Q · filed 2022-11-02 | $39.00M derived: sum of 2 quarters · filed 2022-11-02 | $61.00M 10-Q · filed 2022-11-02 | $81.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-06-30 | $20.00M 10-Q · filed 2022-08-03 | $42.00M 10-Q · filed 2022-08-03 | $62.00M derived: sum of 3 quarters · filed 2023-05-25 | $79.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-03-31 | $22.00M 10-Q · filed 2022-05-04 | $42.00M derived: sum of 2 quarters · filed 2023-05-25 | $59.00M derived: sum of 3 quarters · filed 2023-05-25 | $82.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2020-12-31 | $20.00M derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25 | $37.00M derived: sum of 2 quarters · filed 2023-05-25 | $60.00M derived: sum of 3 quarters · filed 2023-05-25 | $80.00M 8-K · filed 2023-05-25 |
| 2020-09-30 | $17.00M 10-Q · filed 2021-11-03 | $40.00M derived: sum of 2 quarters · filed 2021-11-03 | $60.00M 10-Q · filed 2021-11-03 | $79.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $23.00M 10-Q · filed 2021-08-04 | $43.00M 10-Q · filed 2021-08-04 | $62.00M derived: sum of 3 quarters · filed 2022-02-09 | $117.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $20.00M 10-Q · filed 2021-05-04 | $39.00M derived: sum of 2 quarters · filed 2022-02-09 | $94.00M derived: sum of 3 quarters · filed 2022-02-09 | $131.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $74.00M derived: sum of 2 quarters · filed 2022-02-09 | $111.00M derived: sum of 3 quarters · filed 2022-02-09 | $146.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $55.00M 10-Q · filed 2020-11-06 | $92.00M derived: sum of 2 quarters · filed 2020-11-06 | $127.00M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $37.00M 10-Q · filed 2020-08-05 | $72.00M 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $35.00M 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $2.00M 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |